Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.0900 (-1.07%) ($5.0900 - $5.0900) on Thu. Mar. 18, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.93% (three month average) | RSI | 34 | Latest Price | $5.0900(-1.07%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -2.1% a day on average for past five trading days. | Weekly Trend | CAPR declines -5.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) TAN(32%) ACES(31%) ARKG(45%) SPLV(38%) SMH(35%) | Factors Impacting CAPR price | CAPR will decline at least -3.965% in a week (0% probabilities). OIH(-65%) USO(-37%) PEJ(-31%) IWD(-10%) UNG(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.965% (StdDev 7.93%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-18.94(-472.1%) | Resistance Level | $5.68 | 5 Day Moving Average | $5.08(0.2%) | 10 Day Moving Average | $5.23(-2.68%) | 20 Day Moving Average | $5.68(-10.39%) | To recent high | -35.9% | To recent low | 0% | Market Cap | $100m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |